USD 28.5 billion
Report ID:
SQMIG35H2303 |
Region:
Global |
Published Date: November, 2024
Pages:
182
|Tables:
97
|Figures:
76
Global Artificial Organs Market size was valued at USD 28.5 billion in 2023 and is poised to grow from USD 30.75 billion in 2024 to USD 56.5 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).
The increasing number of elderly people worldwide is making organ transplantation especially important. The number of people over 65 years of age receiving and seeking organ transplants is increasing. The demand for prosthetic devices is higher in the elderly population, as they are more susceptible to post-implantation side effects. According to HRSA, 8,895 organ transplant procedures were performed on people over the age of 65 in the US. in 2022. 42,887 organ transplants were performed in the US. in 2022, up from 2021 by 3.7 percent. So, with increasing age increasing demand organ donors increase the need for prosthetic devices.
Transplant waiting lists are expected to grow in the coming years as more patients need transplants, according to a new study. In March 2023, HRSA announced the OPTN Modernization Initiative aimed at improving system quality, accountability and efficiency by updating OPTN technology, data transparency and analytics, governance, management, improvements which will occur on quality and innovation.
Advances in 3D bioprinting in organ transplantation have proven to be important because they are used to create artificial organs. 3D bioprinting is very popular because it reduces the risk of organ rejection. Moreover, artificial intelligence is poised to revolutionize the global trends in manufacturing technology. Currently, many countries are focusing on developing a tool that provides customized organ and donor assessment. This tool will greatly help in effective decision-making regarding organ recovery and will also help patients decide whether to accept a donor organ or wait for better options.
Market snapshot - 2025-2032
Global Market Size
USD 28.5 billion
Largest Segment
Artificial Organs
Fastest Growth
Artificial Bionics
Growth Rate
7.9% CAGR
To get more reports on the above market click here to Buy The Report
Global Artificial Organs Market is segmented by Organ Type, Fixation, End-User and region. Based on Organ Type, the market is segmented into Artificial kidney, Artificial liver, Artificial lungs, Artificial pancreas, Artificial heart and Other organ types. Based on Fixation, the market is segmented into Implantable and Wearable. Based on End-User, the market is segmented into Hospitals, Academic and Research Institutes and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The mechanical segment dominated the market with the highest revenue growth of 66.9% in 2022. This is due to higher organ failure and lower cost of mechanical bionics. Mechanical heart valve durability is significant when compared to other methods, resulting in strong demand. Other factors driving the growth include faster FDA approvals and reimbursement arrangements. For example, in September 2021, the FDA approved the Abbott Portico a FlexNav TAVR system for the treatment of individuals with symptomatic and diseased aortic stenosis who may be at high or very high risk for open heart surgery.
The electronics segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. According to Bionics Queensland, there are approximately 1.0 billion people with physical disabilities, and 190 million adults with major functional challenges. In most developing countries, infrastructure and financial constraints remain high. For many people with disabilities, the only option is to receive prosthetic limbs. These exercisers are myoelectrically controlled battery-electronic systems and can stimulate muscles through sensors. These sensory electronics allow prosthetics to move. Machine learning, smart wearables and element modelling are being used to make progress. Also, increasing accidents, amputees and increasing number of limbless people are expected to drive the demand for electronic bionics.
The artificial organs segment dominated the market with a high revenue growth of 70.4% in 2022. The demand for kidney, heart, lung and liver transplants contributes to the average growth of this segment waiting for a kidney transplant in the US. is 5 years. Many factors are considered while on the waiting list, including body size, blood type, donor distance, and disease severity. Thus, the challenge of meeting unmet demand is forcing manufacturers to develop wearable bio-lungs, artificial pancreas and artificial kidneys. Artificial organs include devices such as artificial hearts, kidneys, livers, intestines, and lungs that replace or complement natural organs. This category is important because of organ failure due to chronic diseases, due to injuries or age-related circumstances. These are among the most important contributors to the kidney prosthesis stage. For example, SynCardia Systems' Total Artificial Heart provides a life-saving solution for patients waiting for a heart transplant.
The artificial bionics segment is expected to grow at the fastest CAGR of 10.7% during the forecast period from 2024 to 2031. The major factors contributing to the growth of the segment are increasing demand for cochlear implants, vision, exoskeleton, limb, brain bionics fueling the market growth for prosthetics and bionics. For example, in January 2022, Cochlear Limited's cochlear nucleus implants received approval from the US. the Food and Drug Administration to treat unilateral hearing loss and unilateral deafness. Artificial bionics refers to advanced bionic devices that not only recreate the physical structure of human organs or body parts but also enhance the sensitivity or function of those organs. This segment targets individuals in need of a prosthetic device that performs well, allowing for greater mobility and quality of life.
To get detailed analysis on other segments, Request For Free Sample Report
North America ruled the marketplace, accounting for the largest sales share at 45.0% in 2022. This growth is attributed to the rise in transplant surgical operations. Major biotechnology and medical device manufacturers within the place, which include Zimmer Biomet, Arthrex, Inc., Medtronic, Novartis AG, and Stryker, make contributions to this dominance. For example, in March 2022, Zimmer Biomet Holdings, Inc. become acquired. By means of the business enterprise announced WalkAI, a growing AI gadget that identifies patients. The wide variety of donors within the US. Has increased dramatically over the last 5 years.
Asia Pacific is anticipated to witness quickest increase at a CAGR of 11.1% for the duration of the forecast period from 2024 to 2031, driven by way of the emerging economies consisting of Japan, China and India. Chronic diseases leading to the high rates of organ failure are expected to fuel the growth of prosthetic organs and motor devices. In January 2022, Warburg Pincus invested $210 million in Micro Life Sciences Pvt Ltd, the parent organization of Indian medical device company Merrill. The investment will promote domestic high quality regulatory medical devices in a global context, expanding their overseas footprint, attracting international talent, scaling up clinical research programs and potentially. The countries are technologically advanced and offer advanced surgeries with medical tourism growing.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Prevalence of Chronic Diseases
Advances in Medical Technology
High Cost of Prosthetics and Surgery
Risk of Complications and Rejection
Request Free Customization of this report to help us to meet your business objectives.
The Artificial Organs Market is highly competitive, driven by technological innovation and the growing availability of organ replacements. Key players in the market are working to address the gap between increasing organ failure rates, donor availability and transplant needs. Leading companies such as Abbott Laboratories, Medtronic, Zimmer Biomet, Syncardia Systems, Cochlear Ltd. dominate the market with advanced solutions for heart, kidney, liver and cochlear implants. These companies invest heavily in R&D to improve patient outcomes. For example, through innovations in artificial heart and pancreas solutions, as well as strategic acquisitions of subsidiaries, Medtronic has expanded its product portfolio and market presence. Collaboration between leading companies and research institutes accelerates innovation. Strategic partnerships help companies develop next-generation prosthetic limbs, incorporating cutting-edge technologies such as 3D printing and biocompatible materials to drive performance and longevity high.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the increasing incidence of chronic diseases and advances in medicine have led to a greater demand for life-saving solutions. But the market faces challenges due to high cost of prosthetics, challenges and potential risks associated with rejection. Major trends such as the integration of 3D printing with the rise of bioengineered organs plans to restructure the industry, making prosthetics more accessible and effective and continues innovation and increasing investment in research, artificial organs market has great potential for growth in the coming years.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 28.5 billion |
Market size value in 2032 | USD 56.5 billion |
Growth Rate | 7.9% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Artificial Organs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Artificial Organs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Artificial Organs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Artificial Organs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Artificial Organs Market size was valued at USD 47.83 Billion in 2023 and is poised to grow from USD 51.5 Billion in 2024 to USD 93.1 Billion by 2032, growing at a CAGR of 7.68% during the forecast period (2025-2032).
The Artificial Organs Market is highly competitive, driven by technological innovation and the growing availability of organ replacements. Key players in the market are working to address the gap between increasing organ failure rates, donor availability and transplant needs. Leading companies such as Abbott Laboratories, Medtronic, Zimmer Biomet, Syncardia Systems, Cochlear Ltd. dominate the market with advanced solutions for heart, kidney, liver and cochlear implants. These companies invest heavily in R&D to improve patient outcomes. For example, through innovations in artificial heart and pancreas solutions, as well as strategic acquisitions of subsidiaries, Medtronic has expanded its product portfolio and market presence. Collaboration between leading companies and research institutes accelerates innovation. Strategic partnerships help companies develop next-generation prosthetic limbs, incorporating cutting-edge technologies such as 3D printing and biocompatible materials to drive performance and longevity high. 'Edwards Lifesciences Corporation ', 'Cochlear Limited ', 'Zimmer Biomet Holding Inc. ', 'Jarvik Heart, Inc. ', 'Boston Scientific Corporation ', 'Berlin Heart GmbH ', 'SynCardia Systems LLC ', 'CARMAT ', 'BiVACOR Inc. ', 'AWAK Technologies ', 'Wearable Artificial Organs, Inc. ', 'Medtronic Plc ', 'ALung Technologies, Inc. ', 'Fresenius Medical Care ', 'Johnson & Johnson ', 'TransMedics, Inc ', 'Abott'
Increasing incidence of chronic diseases such as kidney failure, heart disease and liver disease is a major driver of the artificial organs market. While many patients are suffering from organ dysfunction the demand for prosthetic organs such as dialysis machines, artificial hearts and liver support systems continues to rise. This increased demand for an ageing population, poor quality of life has more fuel, creating a greater need for the life-saving exercises.
Integration of 3D Printing in Prosthetics: 3D printing is revolutionizing the artificial organs market by enabling customized, patient-specific organs. This technology improves the accuracy, functionality and biocompatibility of complex organ systems. In addition, 3D printing can reduce prosthesis costs and shorten manufacturing time, making this technology a growing market segment.
North America ruled the marketplace, accounting for the largest sales share at 45.0% in 2022. This growth is attributed to the rise in transplant surgical operations. Major biotechnology and medical device manufacturers within the place, which include Zimmer Biomet, Arthrex, Inc., Medtronic, Novartis AG, and Stryker, make contributions to this dominance. For example, in March 2022, Zimmer Biomet Holdings, Inc. become acquired. By means of the business enterprise announced WalkAI, a growing AI gadget that identifies patients. The wide variety of donors within the US. Has increased dramatically over the last 5 years. Asia Pacific is anticipated to witness quickest increase at a CAGR of 11.1% for the duration of the forecast period from 2024 to 2031, driven by way of the emerging economies consisting of Japan, China and India. Chronic diseases leading to the high rates of organ failure are expected to fuel the growth of prosthetic organs and motor devices. In January 2022, Warburg Pincus invested $210 million in Micro Life Sciences Pvt Ltd, the parent organization of Indian medical device company Merrill. The investment will promote domestic high quality regulatory medical devices in a global context, expanding their overseas footprint, attracting international talent, scaling up clinical research programs and potentially. The countries are technologically advanced and offer advanced surgeries with medical tourism growing.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35H2303
[email protected]
USA +1 351-333-4748